Offer - Urjas Oil for just ₹ 1 X
Amikop 250 Injection is a commercial drug that is prescribed in the form of Injection. Urinary Tract Infection are some of its major therapeutic uses. Amikop 250 Injection also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Amikop 250 Injection. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Amikop 250 Injection as well, which are listed below. These side effects of Amikop 250 Injection are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Amikop 250 Injection has a Severe effect for pregnant women and Unknown effect on lactating mothers. In addition, Amikop 250 Injection's effects on the liver, heart and kidney are discussed below in the Amikop 250 Injection related warnings section.
Amikop 250 Injection is not recommended if you suffer from certain medical conditions as it can have adverse effects. Dehydration, Parkinson's Disease, Hearing Loss are examples of such conditions. The section on Amikop 250 Injection contraindications lists all such conditions.
Drug reaction of Amikop 250 Injection with other medicines has been reported. See below for a complete list.
In addition to the above precautions for Amikop 250 Injection, it is important to know that it is safe while driving, and is habit-forming.
Amikop 250 Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
Infant (1 month to 2 years) |
|
Neonates (0 to 1 month) |
|
2 - 12 years (Child) |
|
Is the use of Amikop 250 Injection safe for pregnant women?
Pregnant women may get severe side effects after taking Amikop. If you are pregnant, do not take Amikop without a doctor's advice.
Is the use of Amikop 250 Injection safe during breastfeeding?
Information about safety of Amikop for women who are breastfeeding is not available since scientific research on this is yet to be done.
What is the effect of Amikop 250 Injection on the Kidneys?
Use of Amikop may be dangerous for kidney. Do not use it without doctor advice.
What is the effect of Amikop 250 Injection on the Liver?
Side effects of Amikop rarely affect the liver.
What is the effect of Amikop 250 Injection on the Heart?
Amikop has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Amikop 250 Injection unless your doctor advises you to do so -
Is this Amikop 250 Injection habit forming or addictive?
No, you will not get addicted to Amikop 250 Injection.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Amikop 250 Injection as it does not make you drowsy.
Is it safe?
Amikop 250 Injection is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Amikop 250 Injection cannot treat any kind of mental disorder.
Interaction between Food and Amikop 250 Injection
Taking Amikop 250 Injection with food does not cause any problems.
Interaction between Alcohol and Amikop 250 Injection
It is difficult to say anything about the effect of Amikop 250 Injection and alcohol. No research has been done on this yet.
No, Amikop cannot be taken with penicillin. Because penicillin inactivates the Amikop by combining the beta-lactam ring of penicillin with an amino group of this drug to form amide which is biologically inactive. For this reason Amikop should not be taken with penicillin. The chances of inactivation of this drug are higher in case of renal failure because in this case concentration of penicillin is higher in the kidney for a longer time as compared to the normal renal function.
No, Amikop does not cause constipation in patients who are taking it. However, if you are experiencing constipation after taking this drug then inform your doctor and take precautionary methods such as eating fibrous foods to avoid constipation.
Amikop is a brand name for amikacin. It is a prescription drug which belongs to the class of medication known as an aminoglycoside antibiotic. It is a broad spectrum antibiotic which is used for the treatment of bacterial infection such as bone, joint, skin, intra-abdominal, pneumonia, and respiratory tract infection. It is used for short-term treatment (7 - 10 days) of bacterial infection in different part of the body. It is also used for the treatment of neonatal sepsis when sensitivity testing indicates that other aminoglycosides cannot be used.
Yes, Amikop has been reported to cause ototoxicity (hearing loss or deafness) which is irreversible and may progress after discontinuation of the drug. It is a common side effect of this medicine. If you experience hearing loss or deafness after consuming or applying for this medicine, then consult your doctor and follow his/her instructions.
Yes, Amikop can be taken with lidocaine. The clinical report suggests that no harmful drug-drug interactions have been observed between them so far. However, it doesn't mean that no interaction could exist between them. These two medicines are high alert drug so you must consult your doctor before taking Amikop together.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Arikayce (amikacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 749
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 136-137